- ￥485 - 3541
- TargetMol
- USA
- T1787
- 2025年07月15日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件：
-20°C
- 保质期：
For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -1818℃ for several months.
- 英文名：
Levobupivacaine
- 库存：
详询
- 供应商：
详询
- CAS号：
27262-47-1
- 规格：
2mg/5mg/10mg/50mg/1ml/10mM
| 规格： | 2mg | 产品价格： | ￥485.0 |
|---|---|---|---|
| 规格： | 5mg | 产品价格： | ￥723.0 |
| 规格： | 10mg | 产品价格： | ￥923.0 |
| 规格： | 50mg | 产品价格： | ￥3541.0 |
| 规格： | 1ml/10mM | 产品价格： | ￥1669.0 |
ID：T1787
PURITY：0.98
Formula：C18H28N2O
MolWt：288.43
Appearance：白色粉末
Solubility：G4Soluble in DMSO
Bioactivity：Levobupivacaine is an amino-amide local anaesthetic drug belonging to the family of n-alkylsubstituted pipecoloxylidide. It is the S-enantiomer of bupivacaine. Levobupivacaine hydrochloride is commonly marketed by AstraZeneca under the trade name Chirocaine. Compared to bupivacaine, levobupivacaine is associated with less vasodilation and has a longer duration of action. It is approximately 13 per cent less potent (by molarity) than racemic bupivacaine.Levobupivacaine is indicated for local anaesthesia including infiltration, nerve block, ophthalmic, epidural and intrathecal anaesthesia in adults; and infiltration analgesia in children. Adverse drug reactions (ADRs) are rare when it is administered correctly. Most ADRs relate to administration technique (resulting in systemic exposure) or pharmacological effects of anesthesia, however allergic reactions can rarely occur.
Status：
Pathways：Membrane Transporter/Ion Channel
Target：Sodium Channel inhibitor
Receptor：Sodium channel
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
